Ms. Watts has an impressive track record as a leader in global clinical operations for over two decades. Her primary focus has been on enhancing and optimizing the operational performance and strategic execution of clinical programs.
During recent years, Ms. Watts has held the position of Vice President, Clinical Operations at several clinical-stage biopharmaceutical companies, including Complement Therapeutics, Oculis, and Graybug Vision. Prior to that, she served as the Clinical Sciences Director of Ophthalmology – Retina Lead at the Novartis Institute of Biomedical Research. In addition to her extensive experience in ophthalmology, Ms. Watts successfully oversaw early to late-stage clinical trials across various medical fields, including Respiratory, Immunology, Oncology, Cardiology, and COVID-19. Her leadership also extended to global clinical programs at Genentech, Actelion, and Gilead Sciences.
Ms. Watts holds a specialized Master of Science degree in Clinical Research Management from the School of Biomedical Science at the University of North Texas Health Science Center (UNTHSC) in Fort Worth, Texas.